✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹638 Cr.
P/E
19.30

Key Ratios

Market cap
Market cap
638 Cr
PE
PE
19.30
Prom Holding
Prom Holding
55.09 %
ROE (%)
ROE (%)
18.41
ROCE (%)
ROCE (%)
23.16
Div Yield (%)
Div Yield (%)
0.38
Sales
Sales
264 Cr
OPM (%)
OPM (%)
15.84 %
Debt to Equity
Debt to Equity
0.08
About
Accent Microcell Limited specializes in manufacturing a range of Pharmaceutical Excipients, wi… Read more
Low
170
52W Range
High
298
  • Accent Microcell
  • Zim Laboratories
  • Medicamen Biotech

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
Corporate Actions
Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less
FAQs on Accent Microcell Ltd. Business

Accent Microcell Limited is engaged in the manufacturing business of Pharmaceutical Excipients Range of Product. The company has carved a niche in the production of high-quality cellulose-based excipients, that meet international quality standards.

Accent Microcell major competitors are Zim Laboratories, Medicamen Biotech, Jenburkt Pharma, Shukra Pharma, Valiant Laboratories, Nectar Lifesciences, Venus Remedies.
Market Cap of Accent Microcell is ₹638 Crs.
While the median market cap of its peers are ₹565 Crs.

Accent Microcell seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material